Kessoku Takaomi

J-GLOBAL         Last updated: Nov 15, 2018 at 14:55
Kessoku Takaomi
Yokohama City University
Hospital, Palliative Care Medical Department
Job title
Assistant Professor
Research funding number

Research Areas


Published Papers

Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.
Honda Y, Kessoku T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, Takizawa T, Saito S, Nagashima Y, Nakajima A.
Sci Rep      Feb 2017   [Refereed]
Higurashi T, Hosono K, Takahashi H, Komiya Y, Umezawa S, Sakai E, Uchiyama T, Taniguchi L, Hata Y, Uchiyama S, Hattori A, Nagase H, Kessoku T, Arimoto J, Matsuhashi N, Inayama Y, Yamanaka S, Taguri M, Nakajima A.
Lancet Oncol      Apr 2016   [Refereed]
Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A.
Gastroenterology      Mar 2016   [Refereed]


Usefulness of Suvorexant for Complicated Delirium in Cancer Patients Who Experience Sleep Disturbance during Hospitalization
Kessoku Takaomi
Gan To Kagaku Ryoho      Mar 2018   [Refereed]
Assessing Patient Factors Influencing the Discontinuation of Opioids after Intra-Arterial Chemotherapy for Oral Cancer - A Retrospective Study
Kessoku Takaomi
Gan To Kagaku Ryoho      Mar 2018   [Refereed]
Fentanyl Citrate Sublingual Tablets Were Effective in Relieving Symptoms of Akathisia - A Case Report
Kessoku Takaomi
Gan To Kagaku Ryoho      Mar 2018
Gut microbiota and nonalcoholic steatohepatitis
Kessoku Takaomi
Nihon Yakurigaku Zasshi      2018   [Refereed][Invited]